No association between vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) and the variability of warfarin dose requirement in a Japanese patient population.
Yin
Tong
T
Research Institute, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan.
Hanada
Hironori
H
Miyashita
Kotaro
K
Kokubo
Yoshihiro
Y
Akaiwa
Yasuhisa
Y
Otsubo
Ryoichi
R
Nagatsuka
Kazuyuki
K
Otsuki
Toshiho
T
Okayama
Akira
A
Minematsu
Kazuo
K
Naritomi
Hiroaki
H
Tomoike
Hitonobu
H
Miyata
Toshiyuki
T
D000368:Aged; D000595:Amino Acid Sequence; D005260:Female; D006239:Haplotypes; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D006899:Mixed Function Oxygenases / Q000235:genetics* / Q000502:physiology; D008969:Molecular Sequence Data; D010597:Pharmacogenetics / Q000379:methods*; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D017386:Sequence Homology, Amino Acid; D064417:Vitamin K Epoxide Reductases; D014859:Warfarin / Q000008:administration & dosage*
D014859:Warfarin; D006899:Mixed Function Oxygenases; C578523:VKORC1 protein, human; C531327:VKORC1L1 protein, human; D064417:Vitamin K Epoxide Reductases